NIAID VRC NUCLEIC ACID AND LIPID TECHNOLOGY DEVELOPMENT — VICTORIA COLEMAN (LEIDOS BIOMEDICAL RESEARCH, INC.)
The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development, and clinical testing of vaccines and therapeutics for emerging and endemic infect
| Project title | NIAID VRC NUCLEIC ACID AND LIPID TECHNOLOGY DEVELOPMENT |
|---|---|
| Project number | 75N91019D00024-0-759102300018-1 |
| PI name | VICTORIA COLEMAN |
| Institution | LEIDOS BIOMEDICAL RESEARCH, INC. |
| Funding mechanism | N01 |
| Agency | NIAID |
| Award amount | $7.09M |
| Fiscal year | 2023 |
| Project start | 2023-09-15T00:00:00 |
| Project end | 2028-09-14T00:00:00 |
| Abstract | The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development, and clinical testing of vaccines and therapeutics for emerging and endemic infect |
| Key terms | <AIDS Virus><Acceleration><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Synd |
$799/mo
Try GrantRadar →